BioSpace News Archive

SenesTech, Inc., a developer of proprietary technologies for managing animal pest populations through fertility control, encourages businesses and pest management professionals to deploy ContraPest® in their integrated pest management programs to enhance rat control as communities begin to reopen.

New Patent Filing Suggests Novel Mechanism of Immune Boosting Nutraceutical Can Augment Efficacy of Cancer Immunotherapy

Motus GI Holdings, Inc. , (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that Timothy P. Moran, Chief Executive Officer of Motus GI, will present at the Virtual Investor Fireside Chat Series on Monday, June 15, 2020,

Company Owns and Operates Over 120,000 Square Feet of U.S. cGMP and DEA-Licensed Contract Development and Manufacturing Facilities Focused on Creating Oral, Solid Dose Drug Products

Exeltis USA, Inc, a division of Insud Pharma, today released a physician and patient communication letter announcing a recent publication in Drugs of Today 2020 that highlights the Slynd safety data and the efficacy of drospirenone to inhibit ovulation, reinforcing the features and benefits of Slynd

Miami Beach Medical Group Medical Centers (“MBMG”) announced today that Efrain Duarte will assume the Chief Executive Officer (“CEO”) role, and Dr. Rodolfo Dumenigo, who is the Founder, is named Chairman of the Board and will assume the role of Chief Medical Officer.

Blauer Manufacturing announced that it received formal 3rd party certification for its new BIO-99™ coverall to the NFPA 1999 Standard on Protective Clothing and Ensembles for Emergency Medical Operations for multiple-use.

Solvias, a world leader in contract research, development and manufacturing, today announced that it has completed an agreement with strategic health care investors, Water Street Healthcare Partners and JLL Partners, to fully acquire and invest in growing Solvias.

EpicGenetics to offer a no-fee immune system COVID-19 FDA-authorized antibody test with every FM/a® Test

The Evanston Group, a life sciences consulting firm nationally recognized for making precise matches of specialty talent and experienced consultants for global pharmaceutical, medical device and other companies, today announced the addition of a new executive team led by Michael Romero, President & Chief Revenue Officer, and Nick Katzenbach, Senior Vice President.